Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | MAP2K1 |
Variant | I104_P105del |
Impact List | deletion |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | MAP2K1 I104_P105del results in the deletion of two amino acids in the protein kinase domain of the Map2k1 protein from amino acids 104 to 105 (UniProt.org). I104_P105del results in increased Erk phosphorylation in cultured cells (PMID: 32641410), and therefore, is predicted to lead to a gain of Map2k1 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
MAP2K1 mutant MAP2K1 act mut MAP2K1 I104_P105del |
Transcript | NM_002755.4 |
gDNA | chr15:g.66436764_66436769delAAACCC |
cDNA | c.310_315delAAACCC |
Protein | p.K104_P105delKP |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017022411 | chr15:g.66436764_66436769delAAACCC | c.310_315delAAACCC | p.K104_P105delKP | RefSeq | GRCh38/hg38 |
XM_017022411.3 | chr15:g.66436764_66436769delAAACCC | c.310_315delAAACCC | p.K104_P105delKP | RefSeq | GRCh38/hg38 |
XM_011521783.4 | chr15:g.66436830_66436835delATCGTG | c.310_315delATCGTG | p.I104_V105delIV | RefSeq | GRCh38/hg38 |
NM_001411065.1 | chr15:g.66436830_66436835delATCGTG | c.310_315delATCGTG | p.I104_V105delIV | RefSeq | GRCh38/hg38 |
NM_002755.4 | chr15:g.66436764_66436769delAAACCC | c.310_315delAAACCC | p.K104_P105delKP | RefSeq | GRCh38/hg38 |
NM_002755.3 | chr15:g.66436764_66436769delAAACCC | c.310_315delAAACCC | p.K104_P105delKP | RefSeq | GRCh38/hg38 |
XM_017022411.2 | chr15:g.66436764_66436769delAAACCC | c.310_315delAAACCC | p.K104_P105delKP | RefSeq | GRCh38/hg38 |
XM_017022413 | chr15:g.66485136_66485141delAGGAGA | c.312_317delAGGAGA | p.E104_G105delEG | RefSeq | GRCh38/hg38 |
XM_017022412.1 | chr15:g.66436830_66436835delATCGTG | c.310_315delATCGTG | p.I104_V105delIV | RefSeq | GRCh38/hg38 |
XM_011521783.3 | chr15:g.66436830_66436835delATCGTG | c.310_315delATCGTG | p.I104_V105delIV | RefSeq | GRCh38/hg38 |
XM_017022412 | chr15:g.66436830_66436835delATCGTG | c.310_315delATCGTG | p.I104_V105delIV | RefSeq | GRCh38/hg38 |
NM_002755 | chr15:g.66436764_66436769delAAACCC | c.310_315delAAACCC | p.K104_P105delKP | RefSeq | GRCh38/hg38 |
XM_011521783 | chr15:g.66436830_66436835delATCGTG | c.310_315delATCGTG | p.I104_V105delIV | RefSeq | GRCh38/hg38 |
XM_017022413.1 | chr15:g.66485136_66485141delAGGAGA | c.312_317delAGGAGA | p.E104_G105delEG | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|